168 related articles for article (PubMed ID: 15767853)
1. Inherited disorders of HDL metabolism and atherosclerosis.
Hovingh GK; de Groot E; van der Steeg W; Boekholdt SM; Hutten BA; Kuivenhoven JA; Kastelein JJ
Curr Opin Lipidol; 2005 Apr; 16(2):139-45. PubMed ID: 15767853
[TBL] [Abstract][Full Text] [Related]
2. Plasma levels of 27-hydroxycholesterol in humans and mice with monogenic disturbances of high density lipoprotein metabolism.
Karuna R; Holleboom AG; Motazacker MM; Kuivenhoven JA; Frikke-Schmidt R; Tybjaerg-Hansen A; Georgopoulos S; van Eck M; van Berkel TJ; von Eckardstein A; Rentsch KM
Atherosclerosis; 2011 Feb; 214(2):448-55. PubMed ID: 21130455
[TBL] [Abstract][Full Text] [Related]
3. Increased risk of coronary artery disease in Caucasians with extremely low HDL cholesterol due to mutations in ABCA1, APOA1, and LCAT.
Tietjen I; Hovingh GK; Singaraja R; Radomski C; McEwen J; Chan E; Mattice M; Legendre A; Kastelein JJ; Hayden MR
Biochim Biophys Acta; 2012 Mar; 1821(3):416-24. PubMed ID: 21875686
[TBL] [Abstract][Full Text] [Related]
4. Molecular genetic study of Finns with hypoalphalipoproteinemia and hyperalphalipoproteinemia: a novel Gly230 Arg mutation (LCAT[Fin]) of lecithin:cholesterol acyltransferase (LCAT) accounts for 5% of cases with very low serum HDL cholesterol levels.
Miettinen HE; Gylling H; Tenhunen J; Virtamo J; Jauhiainen M; Huttunen JK; Kantola I; Miettinen TA; Kontula K
Arterioscler Thromb Vasc Biol; 1998 Apr; 18(4):591-8. PubMed ID: 9555865
[TBL] [Abstract][Full Text] [Related]
5. Characterization of antioxidant/anti-inflammatory properties and apoA-I-containing subpopulations of HDL from family subjects with monogenic low HDL disorders.
Daniil G; Phedonos AA; Holleboom AG; Motazacker MM; Argyri L; Kuivenhoven JA; Chroni A
Clin Chim Acta; 2011 Jun; 412(13-14):1213-20. PubMed ID: 21420943
[TBL] [Abstract][Full Text] [Related]
6. The genetics of high-density lipoprotein metabolism: clinical relevance for therapeutic approaches.
Strang AC; Hovingh GK; Stroes ES; Kastelein JJ
Am J Cardiol; 2009 Nov; 104(10 Suppl):22E-31E. PubMed ID: 19895941
[TBL] [Abstract][Full Text] [Related]
7. Increased risk of premature coronary artery disease in Egyptians with ABCA1 (R219K), CETP (TaqIB), and LCAT (4886C/T) genes polymorphism.
Abd El-Aziz TA; Mohamed RH; Hagrass HA
J Clin Lipidol; 2014; 8(4):381-9. PubMed ID: 25110219
[TBL] [Abstract][Full Text] [Related]
8. Role of apoA-I, ABCA1, LCAT, and SR-BI in the biogenesis of HDL.
Zannis VI; Chroni A; Krieger M
J Mol Med (Berl); 2006 Apr; 84(4):276-94. PubMed ID: 16501936
[TBL] [Abstract][Full Text] [Related]
9. Association between increased arterial-wall thickness and impairment in ABCA1-driven cholesterol efflux: an observational study.
van Dam MJ; de Groot E; Clee SM; Hovingh GK; Roelants R; Brooks-Wilson A; Zwinderman AH; Smit AJ; Smelt AH; Groen AK; Hayden MR; Kastelein JJ
Lancet; 2002 Jan; 359(9300):37-42. PubMed ID: 11809185
[TBL] [Abstract][Full Text] [Related]
10. Common variants of multiple genes that control reverse cholesterol transport together explain only a minor part of the variation of HDL cholesterol levels.
Boekholdt SM; Souverein OW; Tanck MW; Hovingh GK; Kuivenhoven JA; Peters RI; Jansen H; Schiffers PM; van der Wall EE; Doevendans PA; Reitsma PH; Zwinderman AH; Kastelein JJ; Jukema JW
Clin Genet; 2006 Mar; 69(3):263-70. PubMed ID: 16542392
[TBL] [Abstract][Full Text] [Related]
11. Compromised LCAT function is associated with increased atherosclerosis.
Hovingh GK; Hutten BA; Holleboom AG; Petersen W; Rol P; Stalenhoef A; Zwinderman AH; de Groot E; Kastelein JJ; Kuivenhoven JA
Circulation; 2005 Aug; 112(6):879-84. PubMed ID: 16061733
[TBL] [Abstract][Full Text] [Related]
12. Plasma levels of sphingosine-1-phosphate and apolipoprotein M in patients with monogenic disorders of HDL metabolism.
Karuna R; Park R; Othman A; Holleboom AG; Motazacker MM; Sutter I; Kuivenhoven JA; Rohrer L; Matile H; Hornemann T; Stoffel M; Rentsch KM; von Eckardstein A
Atherosclerosis; 2011 Dec; 219(2):855-63. PubMed ID: 21944699
[TBL] [Abstract][Full Text] [Related]
13. Complete and Partial Lecithin:Cholesterol Acyltransferase Deficiency Is Differentially Associated With Atherosclerosis.
Oldoni F; Baldassarre D; Castelnuovo S; Ossoli A; Amato M; van Capelleveen J; Hovingh GK; De Groot E; Bochem A; Simonelli S; Barbieri S; Veglia F; Franceschini G; Kuivenhoven JA; Holleboom AG; Calabresi L
Circulation; 2018 Sep; 138(10):1000-1007. PubMed ID: 29748187
[TBL] [Abstract][Full Text] [Related]
14. Naturally occurring and bioengineered apoA-I mutations that inhibit the conversion of discoidal to spherical HDL: the abnormal HDL phenotypes can be corrected by treatment with LCAT.
Koukos G; Chroni A; Duka A; Kardassis D; Zannis VI
Biochem J; 2007 Aug; 406(1):167-74. PubMed ID: 17506726
[TBL] [Abstract][Full Text] [Related]
15. Tangier disease caused by compound heterozygosity for ABCA1 mutations R282X and Y1532C.
Cameron J; Ranheim T; Halvorsen B; Kulseth MA; Leren TP; Berge KE
Atherosclerosis; 2010 Mar; 209(1):163-6. PubMed ID: 19765707
[TBL] [Abstract][Full Text] [Related]
16. Lack of association between increased carotid intima-media thickening and decreased HDL-cholesterol in a family with a novel ABCA1 variant, G2265T.
Hong SH; Riley W; Rhyne J; Friel G; Miller M
Clin Chem; 2002 Nov; 48(11):2066-70. PubMed ID: 12407001
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein A-IFIN (Leu159-->Arg) mutation affects lecithin cholesterol acyltransferase activation and subclass distribution of HDL but not cholesterol efflux from fibroblasts.
Miettinen HE; Jauhiainen M; Gylling H; Ehnholm S; Palomäki A; Miettinen TA; Kontula K
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3021-32. PubMed ID: 9409289
[TBL] [Abstract][Full Text] [Related]
18. Functional lecithin: cholesterol acyltransferase is not required for efficient atheroprotection in humans.
Calabresi L; Baldassarre D; Castelnuovo S; Conca P; Bocchi L; Candini C; Frigerio B; Amato M; Sirtori CR; Alessandrini P; Arca M; Boscutti G; Cattin L; Gesualdo L; Sampietro T; Vaudo G; Veglia F; Calandra S; Franceschini G
Circulation; 2009 Aug; 120(7):628-35. PubMed ID: 19687369
[TBL] [Abstract][Full Text] [Related]
19. Mouse models of disturbed HDL metabolism.
Hoekstra M; Van Eck M
Handb Exp Pharmacol; 2015; 224():301-36. PubMed ID: 25522993
[TBL] [Abstract][Full Text] [Related]
20. Carriers of lecithin cholesterol acyltransferase gene mutations have accelerated atherogenesis as assessed by carotid 3.0-T magnetic resonance imaging [corrected].
Duivenvoorden R; Holleboom AG; van den Bogaard B; Nederveen AJ; de Groot E; Hutten BA; Schimmel AW; Hovingh GK; Kastelein JJ; Kuivenhoven JA; Stroes ES
J Am Coll Cardiol; 2011 Dec; 58(24):2481-7. PubMed ID: 22133847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
